Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Publication

    Elimination of lymphatic filariasis in west African urban areas: is implementation of mass drug administration necessary?

    Journal: The Lancet Global Health

    Summary

    This personal view examines the challenges and the relevance of mass drug administration (MDA) in urban areas. The authors suggest that MDA might not be essential to interrupt the transmission of lymphatic filariasis in urban areas in west Africa. Evidence shows that transmission levels are low and that effective MDA is difficult to implement, with assessments suggesting that specific control measures against filariasis in such dynamic settings is not an effective use of limited resources.

    Instead, the authors recommend that: 1) individuals who have clinical disease or who test positive for Wucheria bancrofti infection in surveillance activities should be offered antifilarial drugs through a passive surveillance approach, as well as morbidity management for their needs; 2) more precise studies are done, so that MDA in urban areas is considered if sustainable transmission is found to be ongoing.

    Read the full study on PubMed

    Related tags

    Lymphatic filariasis
    Publication details
    Date published
    2 January 2018
    Type
    Journal Title
    Journal
    The Lancet Global Health
    Countries
    Themes/conditions
    Lymphatic filariasis
    Publication details
    Date published
    2 January 2018
    Type
    Journal Title
    Journal
    The Lancet Global Health
    Countries
    Themes/conditions
    Lymphatic filariasis

    Related publications

    Publication

    Use of digital assessment tools to measure health facility readiness to provide the World Health Organization (WHO) recommended package of care for lymphatic filariasis morbidity

    Publication

    Advances in filarial hydrocelectomy reporting in Uganda and Nigeria

    Publication

    The development and roll-out of a new hydrocoele surgery facility assessment tool for the elimination of lymphatic filariasis

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.